Pharma Is Priority As GSK Confirms Split With Consumer
Break-Up By July 2022
With CEO Emma Walmsley determined to keep investing in new technologies, GlaxoSmithKline has launched a two-year program to prepare for the separation of its pharma and consumer healthcare units into two companies.
